Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function

Ágnes Telbisz, L. Homolya

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Introduction: The bile salt export pump (BSEP/ABCB11), residing in the apical membrane of hepatocyte, mediates the secretion of bile salts into the bile. A range of human diseases is associated with the malfunction of BSEP, including fatal hereditary liver disorders and mild cholestatic conditions. Manifestation of these diseases primarily depends on the mutation type; however, other factors such as hormonal changes and drug interactions can also trigger or influence the related diseases.Areas covered: Here, we summarize the recent knowledge on BSEP by covering its transport properties, cellular localization, regulation and major mutations/polymorphisms, as well as the hereditary and acquired diseases associated with BSEP dysfunction. We discuss the different model expression systems employed to understand the function of the BSEP variants, their drug interactions and the contemporary therapeutic interventions.Expert opinion: The limitations of the available model expression systems for BSEP result in controversial conclusions, and obstruct our deeper insight into BSEP deficiencies and BSEP-related drug interactions. The knowledge originating from different methodologies, such as clinical studies, molecular genetics, as well as in vitro and in silico modeling, should be integrated and harmonized. Increasing availability of robust molecular biological tools and our better understanding of the mechanism of BSEP deficiencies should make the personalized, mutation-based therapeutic interventions more attainable.

Original languageEnglish
Pages (from-to)501-514
Number of pages14
JournalExpert Opinion on Therapeutic Targets
Volume20
Issue number4
DOIs
Publication statusPublished - Apr 2 2016

Fingerprint

Drug interactions
Bile Acids and Salts
Drug Interactions
Pumps
Mutation
Inborn Genetic Diseases
Expert Testimony
Bile
Computer Simulation
Molecular Biology
Hepatocytes
Polymorphism
Liver
Transport properties
Membranes
Availability
Therapeutics

Keywords

  • bile salt transport
  • BSEP/ABCB11
  • cholestasis
  • in vitro models
  • mutations
  • pharmacological correction Expert Opin. Ther. Targets (2016)

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function. / Telbisz, Ágnes; Homolya, L.

In: Expert Opinion on Therapeutic Targets, Vol. 20, No. 4, 02.04.2016, p. 501-514.

Research output: Contribution to journalArticle

@article{71d0d06bda074fed8b3cb94b90ad1bf9,
title = "Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function",
abstract = "Introduction: The bile salt export pump (BSEP/ABCB11), residing in the apical membrane of hepatocyte, mediates the secretion of bile salts into the bile. A range of human diseases is associated with the malfunction of BSEP, including fatal hereditary liver disorders and mild cholestatic conditions. Manifestation of these diseases primarily depends on the mutation type; however, other factors such as hormonal changes and drug interactions can also trigger or influence the related diseases.Areas covered: Here, we summarize the recent knowledge on BSEP by covering its transport properties, cellular localization, regulation and major mutations/polymorphisms, as well as the hereditary and acquired diseases associated with BSEP dysfunction. We discuss the different model expression systems employed to understand the function of the BSEP variants, their drug interactions and the contemporary therapeutic interventions.Expert opinion: The limitations of the available model expression systems for BSEP result in controversial conclusions, and obstruct our deeper insight into BSEP deficiencies and BSEP-related drug interactions. The knowledge originating from different methodologies, such as clinical studies, molecular genetics, as well as in vitro and in silico modeling, should be integrated and harmonized. Increasing availability of robust molecular biological tools and our better understanding of the mechanism of BSEP deficiencies should make the personalized, mutation-based therapeutic interventions more attainable.",
keywords = "bile salt transport, BSEP/ABCB11, cholestasis, in vitro models, mutations, pharmacological correction Expert Opin. Ther. Targets (2016)",
author = "{\'A}gnes Telbisz and L. Homolya",
year = "2016",
month = "4",
day = "2",
doi = "10.1517/14728222.2016.1102889",
language = "English",
volume = "20",
pages = "501--514",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function

AU - Telbisz, Ágnes

AU - Homolya, L.

PY - 2016/4/2

Y1 - 2016/4/2

N2 - Introduction: The bile salt export pump (BSEP/ABCB11), residing in the apical membrane of hepatocyte, mediates the secretion of bile salts into the bile. A range of human diseases is associated with the malfunction of BSEP, including fatal hereditary liver disorders and mild cholestatic conditions. Manifestation of these diseases primarily depends on the mutation type; however, other factors such as hormonal changes and drug interactions can also trigger or influence the related diseases.Areas covered: Here, we summarize the recent knowledge on BSEP by covering its transport properties, cellular localization, regulation and major mutations/polymorphisms, as well as the hereditary and acquired diseases associated with BSEP dysfunction. We discuss the different model expression systems employed to understand the function of the BSEP variants, their drug interactions and the contemporary therapeutic interventions.Expert opinion: The limitations of the available model expression systems for BSEP result in controversial conclusions, and obstruct our deeper insight into BSEP deficiencies and BSEP-related drug interactions. The knowledge originating from different methodologies, such as clinical studies, molecular genetics, as well as in vitro and in silico modeling, should be integrated and harmonized. Increasing availability of robust molecular biological tools and our better understanding of the mechanism of BSEP deficiencies should make the personalized, mutation-based therapeutic interventions more attainable.

AB - Introduction: The bile salt export pump (BSEP/ABCB11), residing in the apical membrane of hepatocyte, mediates the secretion of bile salts into the bile. A range of human diseases is associated with the malfunction of BSEP, including fatal hereditary liver disorders and mild cholestatic conditions. Manifestation of these diseases primarily depends on the mutation type; however, other factors such as hormonal changes and drug interactions can also trigger or influence the related diseases.Areas covered: Here, we summarize the recent knowledge on BSEP by covering its transport properties, cellular localization, regulation and major mutations/polymorphisms, as well as the hereditary and acquired diseases associated with BSEP dysfunction. We discuss the different model expression systems employed to understand the function of the BSEP variants, their drug interactions and the contemporary therapeutic interventions.Expert opinion: The limitations of the available model expression systems for BSEP result in controversial conclusions, and obstruct our deeper insight into BSEP deficiencies and BSEP-related drug interactions. The knowledge originating from different methodologies, such as clinical studies, molecular genetics, as well as in vitro and in silico modeling, should be integrated and harmonized. Increasing availability of robust molecular biological tools and our better understanding of the mechanism of BSEP deficiencies should make the personalized, mutation-based therapeutic interventions more attainable.

KW - bile salt transport

KW - BSEP/ABCB11

KW - cholestasis

KW - in vitro models

KW - mutations

KW - pharmacological correction Expert Opin. Ther. Targets (2016)

UR - http://www.scopus.com/inward/record.url?scp=84959135920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959135920&partnerID=8YFLogxK

U2 - 10.1517/14728222.2016.1102889

DO - 10.1517/14728222.2016.1102889

M3 - Article

C2 - 26573700

AN - SCOPUS:84959135920

VL - 20

SP - 501

EP - 514

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 4

ER -